Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Details

v3.22.2.2
Balance Sheet Details
9 Months Ended
Sep. 30, 2022
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Details Balance Sheet Details
Cash, cash equivalents and restricted cash consist of the following:
September 30, 2022 December 31, 2021
(in thousands)
Cash and cash equivalents $ 181,496  $ 130,572 
Short-term restricted cash 971  105 
Long-term restricted cash 26  1,061 
Total cash, cash equivalents and restricted cash $ 182,493  $ 131,738 
As of September 30, 2022 and December 31, 2021, cash and cash equivalents included money market funds of approximately $0.4 million and $20.4 million, respectively. As of September 30, 2022 and December 31, 2021, the Company had restricted cash of approximately $1.0 million and $1.2 million, respectively. The cash is restricted in connection with guarantees for certain import duties and office leases.
Inventory consists of the following:
September 30, 2022 December 31, 2021
(in thousands)
Work-in-process $ 101,637  $ 72,369 
Finished goods 64,333  59,334 
$ 165,970  $ 131,703 
Property and equipment, net consists of the following:
Useful Life
(in Years)
September 30, 2022 December 31, 2021
(in thousands)
Furniture and fixtures 5 $ 3,897  $ 3,917 
Machinery and equipment
3-5
71,383  65,004 
Masks and production equipment
2-5
38,932  32,099 
Software 3 9,977  8,763 
Leasehold improvements
1-5
33,579  30,889 
Construction in progress N/A 4,915  4,647 
162,683  145,319 
Less: accumulated depreciation and amortization (95,602) (84,395)
$ 67,081  $ 60,924 
Depreciation expense for the three months ended September 30, 2022 and 2021 was $5.1 million and $4.7 million, respectively. Depreciation expense for the nine months ended September 30, 2022 and 2021 was $14.7 million and $12.0 million, respectively.
In March 2022, the Company entered into a note receivable with a supplier for $10.0 million, which is included in other long-term assets on the consolidated balance sheet. Repayments of $2.0 million per year are due annually by March 31, in years 2024 through 2027, provided that certain production utilization targets for the prior year are met.
Accrued price protection liability consists of the following activity:
Nine Months Ended September 30,
2022 2021
(in thousands)
Beginning balance $ 40,509  $ 47,766 
Charged as a reduction of revenue 142,473  60,488 
Payments (66,391) (58,843)
Ending balance $ 116,591  $ 49,411 
Accrued expenses and other current liabilities consist of the following:
September 30, 2022 December 31, 2021
(in thousands)
Accrued technology license payments $ 5,878  $ 7,337 
Accrued professional fees 3,934  3,651 
Accrued engineering and production costs 2,787  2,934 
Accrued restructuring 224  320 
Accrued royalty 1,346  2,080 
Short-term lease liabilities 10,437  8,888 
Accrued customer credits 3,118  5,136 
Income tax liability 8,435  7,105 
Customer contract liabilities 1,028  1,044 
Accrued obligations to customers for price adjustments 45,954  6,721 
Accrued obligations to customers for stock rotation rights 1,465  2,847 
Contingent consideration 2,882  — 
Other 6,926  9,205 
$ 94,414  $ 57,268 
The following table summarizes the change in balances of accumulated other comprehensive income (loss) by component:
Cumulative Translation Adjustments Pension and Other Defined Benefit Plan Obligation Total
(in thousands)
Balance at December 31, 2021 $ 21  $ 2,104  $ 2,125 
Other comprehensive loss before reclassifications, net of tax (7,441) —  (7,441)
Balance at September 30, 2022 $ (7,420) $ 2,104  $ (5,316)